Phenytoin for neuropathic pain and fibromyalgia in adults

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 6, 2012, Pages

  Birse, Fraser ^a   Derry, Sheena ^a   Moore, R Andrew ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; PHENYTOIN; PLACEBO; PREGABALIN; ANALGESIC AGENT; ANTICONVULSIVE AGENT;

ADVERSE OUTCOME; ANALGESIC ACTIVITY; ANTICONVULSANT THERAPY; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; FIBROMYALGIA; HUMAN; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT DURATION; ADULT; ANALGESIA; METHODOLOGY; NEURALGIA;

ADULT; ANALGESICS; ANTICONVULSANTS; FIBROMYALGIA; HUMANS; NEURALGIA; PAIN MANAGEMENT; PHENYTOIN;

EID: 84864524242     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009485.pub2     Document Type: Review

References (40)

1. Agarwal S, Malhotra YK, Kalla S, Khullar R, Khare AK. Comparative efficacy of phenytoin, steroid and carbamazepine in herpes zoster and post herpetic neuralgia. Indian Journal of Dermatology, Venereology and Leprology 1991;57:279-83. 2852888
2. Chadda VS, Mathur MS. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. Journal of the Association of Physicians of India 1978;26:403-6. 2852890
3. Lockman LA, Hunninghake DB, Krivit W, Desnick RJ. Relief of pain of Fabry's disease by diphenylhydantoin. Neurology 1973;23:871-5. 2852892
4. McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anaesthesia and Analgesia 1999;89:985-8. 2852894
5. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clinical Pharmacology and Therapeutics 1977;22:196-9. 2852896
6. Shaw J, Hughes CM, Lagan KM, Stevenson MR, Irwin CR, Bell PM. The effect of topical phenytoin on healing in diabetic foot ulcers: a randomized controlled trial. Diabetic Medicine 2011;28(10):1154-7. [DOI: 10.1111/j.1464-5491.2011.03309.x]2852898
7. Yajnik S, Singh GP, Singh G, Kumar M. Phenytoin as a coanalgesic in cancer pain. Journal of Pain and Symptom Management 1992;7:209-13. 2852900
8. American Academy of Neurology. Treatment of painful diabetic neuropathy. www.aan.com/globals/axon/assets/8400.pdf (accessed 8 November 2011).
9. Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008;236(3):380-7. [DOI: 10.1016/j.pain.2007.08.013]
10. Chou R, Norris SL, Carson S, Chan BKS. Drug class review on drugs for neuropathic pain: final report. Drug Class Reviews. Portland: Oregon Health and Science University, 2007.
11. Corrigan R, Derry S, Wiffen PJ, Moore RA. Clonazepam for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2012, Issue 5.
12. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008;9(2):105-21. [DOI: 10.1016/j.jpain.2007.09.005]
13. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118:289-305. [DOI: 10.1016/j.pain.2005.08.013]
14. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010;150:573-81. [DOI: 10.1016/j.pain.2010.06.019]
15. Gustorff B, Dorner T, Likar R, Grisold W, Lawrence K, Schwarz F, et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiologica Scandinavica 2008;52(1):132-6. [DOI: 10.1111/j.1399-6576.2007.01486.x]
16. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006;122(1-2):156-62. [DOI: 10.1016/j.pain.2006.01.030]
17. Jensen TS, Madsen CS, Finnerup NB. Pharmacology and treatment of neuropathic pains. Current Opinion in Neurology 2009;22:467-74. [DOI: 10.1097/WCO.0b013e3283311e13]
18. Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, et al. A new definition of neuropathic pain. Pain 2011 [Epub 14 July 2011]. [DOI: 10.1016/j.pain.2011.06.017]
19. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107:224-33.
20. McQuay H, Carroll D, Jada AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995;311:1047-52.
21. McQuay H, Moore R. An Evidence-based Resource for Pain Relief. Oxford: Oxford University Press, 1998. [ISBN: 0-19-263048-2]
22. McQuay HJ, Smith LA, Moore RA. Chronic pain. In: Stevens A, Raferty J, Mant J, Simpson S editor(s). Health Care Needs Assessment. Oxford: Radcliffe Publishing Ltd, 2007:519-600. [ISBN: 978-1-84619-063-6]
23. Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209-16. [DOI: 10.1016/S0304-3959(98)00140-7]
24. Moore RA, Edwards JE, McQuay HJ. Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain 2005;116(3):322-31. [DOI: 10.1016/j.pain.2005.05.001]
25. Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2009;69(2):374-9. [DOI: 10.1136/ard.2009.107805]
26. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007076]
27. "Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al; ACTINPAIN Writing Group of the IASP Special Interest Group on Systematic Reviews in Pain Relief; Cochrane Pain, Palliative and Supportive Care Systematic Review Group Editors. Pain 2010;150(3):386-9. [DOI: 10.1016/j.pain.2010.05.011]
28. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2]
29. National Institute for Health and Clinical Excellence. Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. egap.evidence.nhs.uk/neuropathic-pain-cg96 (accessed 8 November 2011) 2010.
30. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
31. Reyes Del Paso GA, Pulgar A, Duschek S, Garrido S. Cognitive impairment in fibromyalgia syndrome: the impact of cardiovascular regulation, pain, emotional disorders and medication. European Journal of Pain 2012;16(3):421-9. [DOI: 10.1002/j.1532-2149.2011.00032.x]
32. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD005454.pub2]
33. Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. British Journal Clinical Pharmacology 2008;66(2):266-75. [DOI: 10.1111/j.1365-2125.2008.03200.x]
34. Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology 2008;8:29. [DOI: 10.1186/1471-2377-8-29]
35. Tate R, Rubin LM, Krajewski KC. Treatment of refractory trigeminal neuralgia with intravenous phenytoin. American Journal of Health System Pharmacy 2011;68(21):2059-61. [DOI: 10.2146/ajhp100636]
36. Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD005451.pub2]
37. Wiffen PJ, Derry S, Moore RA. Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD006044.pub3]
38. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 1990;33:160-72.
39. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research 2010;62(5):600-10. [DOI: 10.1002/acr.20140]
40. Wiffen PJ, Collins S, McQuay HJ, Carroll D, Jadad A, Moore RA. WITHDRAWN. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD001133.pub3]